Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Supporters often highlight the possibility for meaningful therapeutic gains, particularly in ailments where conventional medications have proven ineffective. However, this is to evaluate the significant financial burden associated with CPI stem cell th